Based in Pennsylvania, Fox Rothschild's 80-member IP group is an outfit with special technical experience supporting clients in the pharmaceutical, biotechnology, technology, medical devices, communications, entertainment and fashion sectors. Over half of the firm's IP group comprises registered patent attorneys, and more than a dozen from the team possesses advanced degrees in technical disciplines. IP Group Chair Gerard Norton, known by one peer as "one of the best litigators in New Jersey," also co-chairs the pharmaceutical and biotechnology industry practice group. He recently obtained a ruling on behalf of Rutgers University, after persuading the court to recognize the patent eligibility of claims to diagnostic kits and methods for detecting TB. The case successfully overcame difficulties encountered in both the Myriad and Prometheus Supreme Court decisions. He also successfully led a team representing Nature's Plus Nordic against Natural Organics, in the appeal of a $6.4 million judgment.
Richard Woodbridge, out of the Princeton office, concentrates much of his practice on matters involving high technology, and has experience across all aspects of intellectual property. He frequently speaks on IP law, and is the editor and chief of Protecting Intellectual Property Under New Jersey Law, published by the Cambridge Institute. Recently, he created a stronger global trademark by utilizing the Madrid Protocol.
Fox Rothschild is a Philadelphia-based full-service firm with 22 domestic offices. The firm represents clients in the biotechnology, pharmaceutical, medical devices, telecommunications, entertainment and fashion industries. A client mentions being "very satisfied with their work and the result" in an exclusive distribution agreement. Intellectual property department chair James Singer handles transactional, patent, copyright, trade secret, and trademark matters. Xerox Corporation retains him as strategic counsel for a number of patented electronic and software technologies. Michael Leonard, who counsels domestic and international clients in the pharmaceutical, chemical, and publishing industries regarding their trademark and copyright matters, recently served as lead counsel to Montussan Apertifs SAS in a case which involved the requirements for refusing a trademark. His team ultimately prevailed, when judges found that the USPTO's prior refusal to grant the client a trademark was improper.
|Lerner David Littenberg Krumholz & Mentlik|
|McCarter & English|
|Giordano Halleran & Ciesla|
|Norris McLaughlin & Marcus|
|Buchanan Ingersoll & Rooney|
|Caesar Rivise Bernstein Cohen & Pokotilow|
|Morgan Lewis & Bockius|
|Panitch Schwarze Belisario & Nadel|
|Volpe & Koenig|
|Akin Gump Strauss Hauer & Feld|
|Drinker Biddle & Reath|
|Reed Smith Richards Butler|
|The Webb Law Firm|